| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JAT.1683 |
| P698 | PubMed publication ID | 21538408 |
| P2093 | author name string | Bo Li | |
| Li Liu | |||
| Liying Wang | |||
| Chunyan He | |||
| Jianning Sun | |||
| Xiaomeng Liu | |||
| Yongli Yu | |||
| Lianzhong Shen | |||
| Yinzeng Li | |||
| P2860 | cites work | Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration | Q38345478 |
| Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease | Q38363544 | ||
| Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice | Q39912017 | ||
| CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy | Q40382325 | ||
| Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells | Q40382473 | ||
| CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection. | Q42422809 | ||
| Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. | Q42997168 | ||
| Extensive necrosis of visceral melanoma metastases after immunotherapy | Q43111380 | ||
| Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice | Q44687455 | ||
| Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides | Q45251770 | ||
| Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen | Q45262603 | ||
| A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine | Q45396680 | ||
| CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques | Q45420331 | ||
| Immunostimulatory DNA sequences influence the course of adjuvant arthritis | Q46321005 | ||
| CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle | Q47841368 | ||
| New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. | Q47878245 | ||
| Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. | Q51765392 | ||
| Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. | Q51813678 | ||
| In vivo and in vitro effect of killed Propionibacterium acnes and its purified soluble polysaccharide on mouse bone marrow stem cells and dendritic cell differentiation. | Q54642746 | ||
| Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice | Q23917440 | ||
| Toll-like receptors: critical proteins linking innate and acquired immunity | Q29615190 | ||
| Short- and long-term changes in gene expression mediated by the activation of TLR9 | Q33695664 | ||
| Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants | Q33698106 | ||
| Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production | Q33707350 | ||
| CpG motifs in bacterial DNA and their immune effects | Q34542287 | ||
| Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis. | Q34596263 | ||
| Therapeutic potential of Toll-like receptor 9 activation | Q36501229 | ||
| Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice | Q36539044 | ||
| Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin | Q36593534 | ||
| Legionella lipoprotein activates toll-like receptor 2 and induces cytokine production and expression of costimulatory molecules in peritoneal macrophages | Q37411194 | ||
| Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation | Q37422374 | ||
| A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells | Q38308732 | ||
| Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner | Q38333159 | ||
| Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG. | Q38340284 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 60-71 | |
| P577 | publication date | 2011-04-29 | |
| P1433 | published in | Journal of Applied Toxicology | Q3186896 |
| P1476 | title | A safety study of a B-class CpG ODN in Sprague-Dawley rats | |
| P478 | volume | 32 |
| Q27025290 | Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects |
| Q42011532 | Initial preclinical safety of non-replicating human endogenous retrovirus envelope protein-coated baculovirus vector-based vaccines against human papillomavirus |
Search more.